BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25136032)

  • 1. Re: Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Cristóbal I; Rincón R; Manso R; Rojo F; García-Foncillas J
    J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25136032
    [No Abstract]   [Full Text] [Related]  

  • 2. KRAS and cancer stem cells in APC-mutant colorectal cancer.
    Fearon ER; Wicha MS
    J Natl Cancer Inst; 2014 Feb; 106(2):djt444. PubMed ID: 24491303
    [No Abstract]   [Full Text] [Related]  

  • 3. Response.
    Moon BS; Cho YH; Jeong WJ; Choi KY
    J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25136033
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
    J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/beta-catenin signaling in cancer stemness and malignant behavior.
    Fodde R; Brabletz T
    Curr Opin Cell Biol; 2007 Apr; 19(2):150-8. PubMed ID: 17306971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K-ras and Wnt signaling synergize to accelerate prostate tumorigenesis in the mouse.
    Pearson HB; Phesse TJ; Clarke AR
    Cancer Res; 2009 Jan; 69(1):94-101. PubMed ID: 19117991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Wnt signaling in colon cancer stem cells.
    de Sousa EM; Vermeulen L; Richel D; Medema JP
    Clin Cancer Res; 2011 Feb; 17(4):647-53. PubMed ID: 21159886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA binding protein RBM3 increases β-catenin signaling to increase stem cell characteristics in colorectal cancer cells.
    Venugopal A; Subramaniam D; Balmaceda J; Roy B; Dixon DA; Umar S; Weir SJ; Anant S
    Mol Carcinog; 2016 Nov; 55(11):1503-1516. PubMed ID: 26331352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt and Kras signaling-dark siblings in lung cancer.
    Pacheco-Pinedo EC; Morrisey EE
    Oncotarget; 2011 Jul; 2(7):569-74. PubMed ID: 21753228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
    Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
    Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stem cell theory of colorectal cancer and its connection with molecular-biological data].
    Hagymási K; Molnár B; Sipos F; Galamb O; Tulassay Z
    Orv Hetil; 2007 Apr; 148(17):779-85. PubMed ID: 17452307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment.
    Kim JY; Lee HY; Park KK; Choi YK; Nam JS; Hong IS
    Oncotarget; 2016 Apr; 7(15):20395-409. PubMed ID: 26967248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCL9/9L-β-catenin Signaling is Associated With Poor Outcome in Colorectal Cancer.
    Moor AE; Anderle P; Cantù C; Rodriguez P; Wiedemann N; Baruthio F; Deka J; André S; Valenta T; Moor MB; Győrffy B; Barras D; Delorenzi M; Basler K; Aguet M
    EBioMedicine; 2015 Dec; 2(12):1932-43. PubMed ID: 26844272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras stabilization through aberrant activation of Wnt/β-catenin signaling promotes intestinal tumorigenesis.
    Jeong WJ; Yoon J; Park JC; Lee SH; Lee SH; Kaduwal S; Kim H; Yoon JB; Choi KY
    Sci Signal; 2012 Apr; 5(219):ra30. PubMed ID: 22494971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential WNT activity in colorectal cancer confers limited tumorigenic potential and is regulated by MAPK signaling.
    Horst D; Chen J; Morikawa T; Ogino S; Kirchner T; Shivdasani RA
    Cancer Res; 2012 Mar; 72(6):1547-56. PubMed ID: 22318865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/β-catenin and MAPK signaling: allies and enemies in different battlefields.
    Guardavaccaro D; Clevers H
    Sci Signal; 2012 Apr; 5(219):pe15. PubMed ID: 22494969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt signalling pathway in the serrated neoplastic pathway of the colorectum: possible roles and epigenetic regulatory mechanisms.
    Fu X; Li L; Peng Y
    J Clin Pathol; 2012 Aug; 65(8):675-9. PubMed ID: 22412046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic beta-catenin signaling networks in colorectal cancer.
    Fuchs SY; Ougolkov AV; Spiegelman VS; Minamoto T
    Cell Cycle; 2005 Nov; 4(11):1522-39. PubMed ID: 16258275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arl4c is a key regulator of tubulogenesis and tumourigenesis as a target gene of Wnt-β-catenin and growth factor-Ras signalling.
    Matsumoto S; Fujii S; Kikuchi A
    J Biochem; 2017 Jan; 161(1):27-35. PubMed ID: 28053143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt signaling in cancer.
    Zhan T; Rindtorff N; Boutros M
    Oncogene; 2017 Mar; 36(11):1461-1473. PubMed ID: 27617575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.